Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
43.66
+2.55 (+6.20%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
November 08, 2024
Via
ACCESSWIRE
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
November 07, 2024
Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda.
Via
Benzinga
Topics
Government
Exposures
Political
Moderna (MRNA) Q3 2024 Earnings Call Transcript
November 07, 2024
MRNA earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Moderna Q3 Revenue Beats On Updated COVID-19 Vaccine, Slashes Expenses For 2024
November 07, 2024
Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.
Via
Benzinga
Exposures
COVID-19
Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing?
November 07, 2024
The company reported just $10 million in sales of its RSV vaccine, mResvia, widely missing expectations.
Via
Investor's Business Daily
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 07, 2024
Via
ACCESSWIRE
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
November 04, 2024
Via
Benzinga
In-Depth Examination Of 15 Analyst Recommendations For Moderna
November 04, 2024
Via
Benzinga
Moderna to Present at Upcoming Conferences in November 2024
October 31, 2024
Via
ACCESSWIRE
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
November 07, 2024
Via
Benzinga
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped
November 06, 2024
On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. (NASDAQ:MRNA) and Square Inc. (NYSE:SQ). The Moderna Trade
Via
Benzinga
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.
November 06, 2024
Robert Kennedy Jr. revealed Trump's directive to tackle health agency corruption, promote science, and end chronic disease.
Via
Benzinga
Topics
Government
Exposures
Political
These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over
November 06, 2024
Perhaps this list is a good place to start bargain-hunting.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
November 06, 2024
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.
Via
The Motley Fool
Behind the Scenes of Moderna's Latest Options Trends
October 29, 2024
Via
Benzinga
Moderna Unusual Options Activity For October 22
October 22, 2024
Via
Benzinga
A Closer Look at Moderna's Options Market Dynamics
October 21, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 05, 2024
Via
Benzinga
2 Dividend Stocks to Buy for a Lifetime of Passive Income
November 02, 2024
These are the kinds of stocks that can allow investors to sleep easy at night.
Via
The Motley Fool
These 10 Stocks Were S&P 500's Top Performers In Biden's First Year: Could The Trend Continue If Harris Wins 2024 Election?
October 31, 2024
A look at the top 10 performing S&P 500 stocks in 2021 could point to trends to watch if Kamala Harris wins the 2024 election.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Moderna Stock Trading Higher On Monday?
October 28, 2024
Merck and Moderna initiate Phase 3 trial of mRNA-4157 (V940) with Keytruda as adjuvant for NSCLC patients, marking progress in individualized cancer therapies.
Via
Benzinga
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
October 28, 2024
From
Merck & Co., Inc.
Via
Business Wire
Large-Cap Stocks In Trouble - Sunday, Oct. 27
October 27, 2024
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via
Talk Markets
Moderna Named a Top Employer by Science for Tenth Consecutive Year
October 24, 2024
Via
ACCESSWIRE
How Bad Is This News for Novavax?
October 19, 2024
Novavax stock fell 20% in one trading session on the news.
Via
The Motley Fool
Large-Cap Stocks In Trouble - Saturday, Oct. 19
October 19, 2024
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.
Via
Talk Markets
Benzinga Bulls And Bears: Apple, Tesla, Netflix, Oklo — And Dogecoin, Meme Coins Outpace Corporate Giants
October 19, 2024
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Via
Benzinga
Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season
October 18, 2024
Goldman Sachs identified 20 stocks with high short interest that could be primed for a short squeeze. Hint: A pet retailer tops the chart.
Via
Benzinga
Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 17, 2024
S. markets ended Thursday with mixed performance: the Dow Jones Industrial Average climbed 0.4% to 43,239.05.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
October 17, 2024
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.